sleep apnea glp 1 How to Treat Moderate With New GLP-1 Medications Impact of Glucagon-Like Peptide-1 Analogues

Emerging evidence suggests that allulose may exert GLP-1-like effects through multiple pathways: Incretin hormone stimulation : Studies demonstrate that allulose consumption stimulates the release of GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) from intestinal L-cells and K-cells, respectively

SGLT2 inhibitors slow DKD progression mainly by reducing glomerular hyperfiltration

risk ratio [RR], 1.32

doi: 10.1210/edrv.22.6.0447 100 AlvesCFrancoRR

There are some data to suggest that insulin resistance also occurs in PD [70], however, this is controversial since systemic insulin resistance is not present in de novo, medication-free PD patients [71], and brain insulin resistance is not present in cognitively normal PD cases [72]

Madden AM, Smith S